PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Possible genetic link found in treatment-related cognitive issues in children w/ leukemia

Study associates poor neurocognitive outcomes with variations in genes related to brain inflammation and oxidative stress, highlight potential interventions

Possible genetic link found in treatment-related cognitive issues in children w/ leukemia
2014-12-09
(Press-News.org) SAN FRANCISCO (DECEMBER 9, 2014) -Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning and other cognitive functions seen in children treated for acute lymphoblastic leukemia (ALL), according to a study led by researchers from Boston Children's Hospital, The Children's Hospital at Montefiore, and Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

The data, presented at the 56th annual meeting of the American Society of Hematology (abstract #856), suggest that it may be possible to genomically screen ALL patients for their risk of long-term treatment-related effects on memory, attention and learning and to study potential interventions.

"Our goal is to be able to identify who is at risk for cognitive late effects and provide neuroprotective interventions," said study senior author Deborah Waber, PhD, senior associate in psychiatry and director the Learning Disabilities Program in Boston Children's Department of Neurology, who has spent 30 years studying the relationship between cognitive decline and ALL therapy, including cranial radiation and/or chemotherapy to the central nervous system. "This retrospective analysis tells us that going forward we may wish to examine children's genotypes at baseline and conduct prospective research to learn why these specific gene variants may increase risk of toxicity."

ALL is the most common childhood cancer, with survival rates of around 90 percent. ALL patients receive chemotherapy to the central nervous system, and some receive cranial radiation, in order to eliminate cancer cells that can lurk in the brain and raise their risk of relapse. ALL survivors often experience problems with persisting attention, memory and learning, which have been documented by neurocognitive studies conducted in the years after completion of curative treatment.

"The more we look, the more we find that many survivors experience changes in how they think," said study lead author Peter Cole, MD, a pediatric hematologist/oncologist at The Children's Hospital at Montefiore and associate professor of pediatrics at Albert Einstein College of Medicine of Yeshiva University. The variability in these changes, he added, raises an interesting question: "If we give all ALL patients the same treatment, why is it that some of them experience memory or cognitive deficits, but not all of them?"

To determine whether inherited genetic variations might have roles to play, the research team gathered stored blood samples and cognitive function test data (e.g., IQ, memory, attention span, hyperactivity behaviors) on 350 ALL survivors treated at eight centers in the United States and Canada. All of the survivors had been treated on one of two consecutive Dana-Farber Cancer Institute ALL Consortium therapy protocols, 95-01 (1996-2000) or 00-01 (2000-2004).

The researchers then examined each survivor's genome for common variants in 28 genes involved in drug metabolism or cellular damage responses, and then compared the results against the cognitive data.

"We limited ourselves to variants that are present in at least 10 percent of the population, deciding that we were interested in explaining what could be happening in most patients," Cole said.

After controlling for factors such as age at diagnosis, sex, socioeconomic status and whether the child received radiation to the brain, the research team found that variants in four genes--NOS3, SLCO2A1, HFE and COMT--were significantly associated with neurocognitive effects. All four are members of pathways that regulate inflammation in the brain or protect cells from oxidative stress, a form of cellular damage caused by chemotherapy.

The researchers note that the retrospective nature of the study means they cannot prove that the gene variants themselves increased patients' risk of poor neurocognitive outcomes. They are now conducting prospective studies to try to establish that link. Any potential protective interventions would also need to undergo preclinical and clinical testing to rule out the risk of interactions that could negatively impact a patient's likelihood of being cured.

"A major ongoing priority in childhood ALL clinical research is to reduce the toxicity of treatment, and certainly we want to reduce neurocognitive late effects if possible," said Lewis Silverman, MD, clinical director of the Hematologic Malignancy Center at Dana-Farber/Boston Children's, principal investigator of the DFCI ALL Consortium clinical trials group, and a co-author on the study. "Hopefully this work will lead to a way to identify those patients at highest risk of neurocognitive late effects in whom we can focus our research efforts--adjusting our treatment approach or testing novel protective strategies with the goal of reducing the neurocognitive late effects without adversely impacting the chance for cure."

INFORMATION:

The study was supported by research funding from the following sources: St. Baldrick's Foundation to PDC, YF, and DPW; NIH P30 HD18655 to DPW; NIH P01 CA068484 to SES, LBS, DSN and KES; and the Michael J. Garil Fund for Leukemia Research to DPW.

About Boston Children's Hospital Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since1869. More than 1,100 scientists, including seven members of the National Academy of Sciences, 14 members of the Institute of Medicine and 14 members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 395-bed comprehensive center for pediatric and adolescent health care. Boston Children's is also the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's Hospital, visit http://www.vectorblog.org.

About Montefiore Health System Montefiore Health System is a premier academic health system and the University Hospital for Albert Einstein College of Medicine. Combining nationally-recognized clinical excellence with a population health perspective that focuses on the comprehensive needs of the communities it serves, Montefiore delivers coordinated, compassionate, science-driven care where, when and how patients need it most. Montefiore consists of six hospitals and an extended care facility with a total of 2,080 beds, a School of Nursing, and state-of-the-art primary and specialty care provided through a network of more than 150 locations across the region, including the largest school health program in the nation and a home health program. The Children's Hospital at Montefiore is consistently named in U.S. News' "America's Best Children's Hospitals." Montefiore's partnership with Einstein advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. The health system derives its inspiration for excellence from its patients and community, and continues to be on the frontlines of developing innovative approaches to care. For more information please visit http://www.montefiorehealthsystem.org.

About Dana-Farber/Boston Children's Cancer and Blood Disorders Center The Dana-Farber/Boston Children's Cancer and Blood Disorders Center - the nation's #1 pediatric cancer program, according to US News & World Report 2014-15 - brings together two internationally known research and teaching institutions that have provided comprehensive care for pediatric oncology and hematology patients since 1947. The Harvard Medical School affiliates share a clinical staff that delivers inpatient care and surgery at Boston Children's Hospital, outpatient oncology care at Dana-Farber Cancer Institute's Jimmy Fund Clinic and outpatient blood disorders care at Boston Children's.


[Attachments] See images for this press release:
Possible genetic link found in treatment-related cognitive issues in children w/ leukemia Possible genetic link found in treatment-related cognitive issues in children w/ leukemia 2

ELSE PRESS RELEASES FROM THIS DATE:

Nanoscale resistors for quantum devices

Nanoscale resistors for quantum devices
2014-12-09
WASHINGTON, D.C., December 9, 2014 - Researchers from the London Centre for Nanotechnology have made new compact, high-value resistors for nanoscale quantum circuits. The resistors could speed the development of quantum devices for computing and fundamental physics research. The researchers describe the thin-film resistors in an article in the Journal of Applied Physics, from AIP Publishing. One example of an application that requires high-value resistors is the quantum phase-slip (QPS) circuit. A QPS circuit is made from very narrow wires of superconducting material ...

Metal test could help diagnose breast cancer early

2014-12-09
It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early. A team, led by Oxford University scientists, took techniques normally used to analyse trace metal isotopes for studying climate change and planetary formation and applied them to how the human body processes metals. In a world-first the researchers were able to show that changes in the isotopic composition of zinc, which can be detected in a person's breast tissue, could make it possible to identify a 'biomarker' (a measurable ...

People with opioid dependence in recovery show 're-regulation' of reward systems

2014-12-09
December 9, 2014 - Within a few months after drug withdrawal, patients in recovery from dependence on prescription pain medications may show signs that the body's natural reward systems are normalizing, reports a study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. The study by Scott C. Bunce, PhD, of Penn State University College of Medicine, Hershey, and colleagues provides evidence of "physiological re-regulation" ...

Are you helping your toddler's aggressive behavior?

2014-12-09
Physical aggression in toddlers has been thought to be associated with the frustration caused by language problems, but a recent study by researchers at the University of Montreal shows that this isn't the case. The researchers did find, however, that parental behaviours may influence the development of an association between the two problems during early childhood. Frequent hitting, kicking, and a tendency to bite or push others are examples of physical aggression observed in toddlers. "Since the 1940s, studies have observed an association between physical aggression ...

Certain factors influence survival and prognosis for premature infants

2014-12-09
Several factors influence how well a severely premature infant (23 weeks gestation) will do after birth and over the long term, according to researchers at Loyola University Medical Center. These findings were published in the latest issue of the American Journal of Perinatology. Researchers found that males, multiples and premature infants born in a hospital without a neonatal intensive care unit had a significantly higher death rate. Lack of exposure to steroids before birth and lower birth weights also significantly increased the risk for disability. Some studies suggested ...

Epidemiologist publishes model on the impact of a regional foot-and-mouth disease outbreak

2014-12-09
MANHATTAN, Kansas -- A research project in the Kansas State University College of Veterinary Medicine presents the largest model to date for evaluating the impact and control of a potential outbreak of foot-and-mouth disease in livestock. Mike Sanderson, professor of epidemiology in the college's diagnostic medicine and pathobiology department, and Sara McReynolds, a former graduate student of Sanderson's, published the results of their research in the December issue of the journal Preventive Veterinary Medicine. The researchers developed simulation models to assess ...

Wait for it: How do wealth and culture guide international product rollouts?

2014-12-09
How do wealth and culture affect the international success of a new product, especially for those nations that have to wait? According to a new study in the Journal of International Marketing, national wealth and cultural characteristics such as individualism play a large part in citizens' enthusiasm and patience for new products. "Even if they have to wait, consumers in wealthy countries are less hesitant to spend money on new products. Cultural factors such as individualism increase patience for adopting new products because of the high value placed on social uniqueness," ...

New insight into risk of Ankylosing Spondylitis

2014-12-09
Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis. The variation in ERAP1 can be detected by genetic testing which, if available, could lead to people becoming aware of the risk of the condition earlier. Ankylosing Spondylitis is a chronic inflammatory disease which mainly affects joints in the spine. In severe cases, it can eventually cause complete fusion and rigidity of the spine, called "Bamboo spine". It tends to first develop in teenagers ...

Penn researchers show commonalities in how different glassy materials fail

Penn researchers show commonalities in how different glassy materials fail
2014-12-09
Glass is mysterious. It is a broad class of materials that extends well beyond the everyday window pane, but one thing that these disparate glasses seem to have in common is that they have nothing in common when it comes to their internal structures, especially in contrast with highly ordered and patterned crystals. Glassy systems can also range in scale: from things like metallic glasses, composed of atoms, to sandcastles, composed of grains of sand. Researchers at the University of Pennsylvania have now shown an important commonality that seems to extend through the ...

The gold standard

2014-12-09
PITTSBURGH (December 9, 2014) ... Precious elements such as platinum work well as catalysts in chemical reactions, but require large amounts of metal and can be expensive. However, computational modeling below the nanoscale level may allow researchers to design more efficient and affordable catalysts from gold. These novel computer simulations to better explore how catalysts function at the nanoscale, led by researchers at the University of Pittsburgh Swanson School of Engineering, was featured as the cover article in the January issue of "Catalysis Science & Technology," ...

LAST 30 PRESS RELEASES:

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

A step toward plant-based gelatin

ECMWF unveils groundbreaking ML tool for enhanced fire prediction

[Press-News.org] Possible genetic link found in treatment-related cognitive issues in children w/ leukemia
Study associates poor neurocognitive outcomes with variations in genes related to brain inflammation and oxidative stress, highlight potential interventions